Severity
Moderate
FDA Devices recall · Reported April 22, 2020
Extended Expiration Date prior to clearance
Life Technologies Corporation recalled Oncomine Dx Target Test DNA Control-IVD for detection of DNA and RNA isolated from non-sm… - a moderate-severity action.
Oncomine Dx Target Test DNA Control-IVD for detection of DNA and RNA isolated from non-sm… was recalled by Life Technologies Corporation in April 22, 2020. Reason: Extended Expiration Date prior to clearance. Check the official notice for the remedy. Verify recall #Z-1704-2020 with the FDA Devices before acting.
The recall
Life Technologies Corporation issued this moderate-severity FDA Devices recall-Extended Expiration Date prior to clearance.
Sourced from official FDA Devices enforcement records. Verify recall #Z-1704-2020 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.
This FDA Devices action (record #Z-1704-2020) was formally reported on April 22, 2020, with the manufacturer initiating the action on March 16, 2020. It is classified under Moderate severity (Class II), with a current status of Terminated. Life Technologies Corporation is listed as the recalling firm, operating out of Frederick, MD. Federal records list the affected scope as 66 units.
The documented reason for this recall is: Extended Expiration Date prior to clearance Distribution data in the federal record shows the product reached: US Nationwide distribution.. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.
Within the same product category the archive holds 6 closely related recalls, 3 from FDA Devices - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.
Where this recall sits in its category - 40,322 medical devices recalls on record
Of 101,704 recalls in the database, 24,878 are high severity, 72,426 moderate, and 4,400 low. This recall is classified moderate severity.
Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.
Severity
Moderate
Affected scope
66 units
Related Recalls
6
3 from same agency
Oncomine Dx Target Test DNA Control-IVD for detection of DNA and RNA isolated from non-small cell lung cancer (NSCLC) tumor specimens, Catalog Number: A32442.
Extended Expiration Date prior to clearance
| Attribute | Value |
|---|---|
| Agency | U.S. Food and Drug Administration |
| Severity class | Moderate (Class II) |
| Status | Terminated |
| Recall number | Z-1704-2020 |
| Date reported | April 22, 2020 |
| Date initiated | March 16, 2020 |
| Recalling firm | Life Technologies Corporation |
| Firm location | Frederick, MD |
| Affected scope | 66 units |
| Distribution | US Nationwide distribution. |
Profile values are sourced directly from the official FDA Devices enforcement record. Source: U.S. Food and Drug Administration.
What to do with this recall
Match your product against the recall record, then act on the agency remedy.
This page summarizes the official FDA Devices record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.
Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.
· 2026-07-02
· 2026-06-25
· 2026-06-18
GE Medical Systems Information Technologies Inc · 2026-06-03
Medline Industries, LP · 2026-06-03
Compare this recall with Rowenta Recalls Cordless Vacuum Cleaners Due to Risk of Ser… →
Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: FDA Devices, reported April 22, 2020. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of July 2026.